Form 8-K - Current report:
SEC Accession No. 0000950137-04-009841
Filing Date
2004-11-12
Accepted
2004-11-12 11:32:21
Documents
3
Period of Report
2004-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT c89740e8vk.htm 8-K 10084
2 PRESS RELEASE c89740exv99w1.htm EX-99.1 7614
3 GRAPHIC c89740biosantelogo.gif GRAPHIC 10900
  Complete submission text file 0000950137-04-009841.txt   30564
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 041136773
SIC: 2836 Biological Products, (No Diagnostic Substances)